Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Inoperable Bowel Obstruction
NCT00332696Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Primary completion
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Octreotide long-acting injection in intestinal obstruction (2 arms), sponsored by Novartis. Primary endpoint: Number of Participants With Treatment Success. Started Sep 2005; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
intestinal obstruction
Beyond the preview
Go deeper on NCT00332696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332696.